Jeremy Zucker is an associate in Mayer Brown’s New York Corporate & Securities practice group. Jeremy’s practice focuses on mergers and acquisitions, private equity, securities and general corporate matters. He represents public and private companies, as well as private equity funds, in a variety of US and cross-border acquisitions and dispositions, investments, joint ventures, restructurings and other significant transactions. 


Life Sciences

  • Nestlé Health Science in its $2.6 billion acquisition of Aimmune Therapeutics
  • Nestlé Health Science in its acquisition of IM HealthScience with its brands of IBgard®, FDgard®, Fiber Choice® and REMfresh®
  • Progenics Pharmaceuticals in its merger with Lantheus Holdings 
  • Mereo BioPharma in a $70 million PIPE investment from investors led by OrbiMed
  • Strongbridge Biopharma in its sale of Macrilen™ to Novo Nordisk for $145 million plus royalties and the related $36.7 million equity investment by Novo Nordisk in Strongbridge Biopharma
  • Adaptimmune Therapeutics in a $225.5 million follow-on offering of American depositary shares 
  • the underwriters in the $130 million follow-on equity offering of eHealth


  • Altas Partners and its portfolio company Dubois Chemicals in the acquisition of the assets and equity comprising the Cimcool business from Milacron, a wholly-owned subsidiary of Hillenbrand
  • Air Products in its $3.8 billion sale of the performance materials division of its materials technologies segment to Evonik
  • WABCO Holdings in its $7 billion sale to ZF Friedrichshafen
  • Boral Limited in its $950 million senior notes offering

Energy and Infrastructure

  • Argo Infrastructure Partners as lead investor in a $320 million preferred equity consortium investment in TierPoint, a leading provider of secure, connected data center and cloud solutions
  • Fortress Transportation & Infrastructure Investors in an offer to exchange membership interests of its subsidiary, Jefferson Investment Holdings, for substantially all of the interests owned by third party investors in Jefferson Terminal

Insurance and Financial Institutions

  • Randall & Quilter in the sale of $80 million of exchangeable preferred equity of its subsidiary to an investment fund affiliated with 777 Partners 
  • Green Bancorp in its $1 billion stock-for-stock merger with Veritex Holdings
  • TPG Capital and its portfolio company The Warranty Group in The Warranty Group’s $2.5 billion merger with Assurant
  • Selective Insurance Group in its $300 million senior notes offering
  • the underwriters in numerous secondary offerings by shareholders of Houlihan Lokey totaling more than $500 million

Technology and Telecommunications

  • Intelsat in its internal reorganization that resulted in the majority of its operations being owned by a U.S.-based partnership
  • Activision Blizzard in senior notes offerings totaling $2.7 billion
  • the initial purchasers in the $350 million convertible notes offering by Avaya Holdings
  • the initial purchasers and underwriters in the $600 million senior notes offering and $564 million follow-on equity offering by OpenText to finance a portion of the $1.62 billion purchase price for its acquisition of Dell EMC’s enterprise content division

Real Estate and Hospitality

  • Realogy Holdings Corp. in its $550 million senior notes offering
  • New Residential Investment Corp. in its $665 million follow-on equity offering
  • Arbor Realty Trust in numerous offerings of senior notes, convertible notes and common stock totaling over $500 million
  • Western Asset Mortgage Capital Corporation in its $68 million follow-on equity offering
  • the underwriters in numerous secondary offerings by shareholders of Extended Stay and ESH Hospitality totaling approximately $1.95 billion

Includes experience prior to joining Mayer Brown


Duke University School of Law, JD, cum laude
Staff Editor, Duke Law Journal

The Ohio State University, BSBA


  • New York